IPSC

Century Therapeutics Inc
CAPPED RATING

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Century Therapeutics Inc (IPSC) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (C+); its weakest is Growth (D). The rating has held at C for 70 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
C+
Factor Score 2.6 / 5.0
Growth
D
Factor Score 1.3 / 5.0
Profitability
C+
Factor Score 2.8 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA 131.5
Rev Growth YoY -100.0%
Gross Margin N/A
Price Return 3M -12.2%
Price Return 12M 277.9%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 3.7
ROE -42.7%

Historical Factor Score Progression

Held C for 70 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C+ (2.6) D (1.3) C+ (2.8) C (2.4) C- (1.9) C (2.2)
2026-08-04 C+ (2.6) D (1.3) C+ (2.8) C (2.4) C- (1.9) C (2.2)
2026-08-03 C+ (2.6) C- (2.0) C- (2.1) C (2.4) C- (2.0) C (2.2)
2026-08-02 C+ (2.6) C- (2.0) C- (2.1) C (2.4) C- (1.9) C (2.2)
2025-03-31 C+ (2.8) C+ (2.5) C (2.2) C+ (2.7) D+ (1.5) C (2.3)
Page 1 of 4